Prognostic value of cyclin D1 overexpression in correlation with pRb and p53 status in non-small cell lung cancer (NSCLC)

Journal of Cancer Research and Clinical Oncology

Volumn 131, Issue 7, 2005, Pages 479-485

  Dworakowska, Dorota ^a   Jassem, Ewa ^a   Jassem, Jacek ^a   Boltze, Carsten ^b   Wiedorn, Klaus Hermann ^c   Dworakowski, Rafał ^a   Skokowski, Jan ^a   Jaśkiewicz, Kazimierz ^a   Częstochowska, Eugenia ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c KATHARINENHOSPITAL   (Germany)

Author keywords

Cyclin D1; Non small cell lung cancer; Prognostic value

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE ANTI ALKALINE PHOSPHATASE; CYCLIN D1; MONOCLONAL ANTIBODY; PROTEIN P53; RETINOBLASTOMA PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIOACCUMULATION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ENZYME IMMUNOASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 21344469517     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-004-0661-9     Document Type: Article

References (31)

1. Akervall JA, Michalides RJ, Mineta H, Balm A, Borg A, Dictor MR, Jin Y, Loftus B, Mertens F, Wennerberg JP (1997) Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression. Cancer 79:380-389
2. Anton RC, Coffey DM, Gondo MM, Stephenson MA, Brown RW, Cagle PT (2000) The expression of cyclins D1 and E in predicting short-term survival in squamous cell carcinoma of the lung. Mod Pathol 13:1167-1172
3. Betticher DC, Heighway J, Hasleton PS, Altermatt HJ, Ryder WD, Cerny T, Thatcher N (1996) Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer 73:294-300
4. Brambilla E, Moro D, Gazzeri S, Brambilla C (1999) Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance. J Pathol 188:351-60
5. Caputi M, De Luca L, Papaccio G, D'Aponte A, Cavallotti I, Scala P, Scarano F, Manna M, Gualdiero L, De Luca B (1997) Prognostic role of cyclin D1 in non small cell lung cancer: an immunohistochemical analysis. Eur J Histochem 41:133-138
6. De Vita VTJ, Hellman S, Rosenberg SA (1997) Cancer: principles and practices of oncology, 5th edn. Lippincott, Philadelphia
7. Dworakowska D, Gozdz S, Jassem E, Badzio A, Kobierska G, Urbaniak A, Skokowski J, Damps I, Jassem J (2002) Prognostic relevance of proliferating cell nuclear antigen and p53 expression in non-small cell lung cancer. Lung Cancer 35:35-41
8. Dworakowska D, Jassem E, Jassem J, Wiedorn KH, Boltze C, Karoliński A, Dworakowski R, Skokowski J, Jaśkiewicz K, Bosse A, Czȩstochowska E (2004) Prognostic relevance of altered pRb and p53 protein expression in surgically treated non-small cell lung cancer patients. Oncology 67:60-66
9. Gugger M, Kappeler A, Vonlanthen S, Altermatt HJ, Ris HB, Lardinois D, Borner MM, Heighway J, Betticher DC (2001) Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours. Lung Cancer 33:229-239
10. Ikehara M, Oshita F, Ito H, Ohgane N, Suzuki R, Saito H, Yamada K, Noda K, Mitsuda A, Kameda Y (2003) Expression of cyclin D1 but not of cyclin E is an indicator of poor prognosis in small adenocarcinomas of the lung. Oncol Rep 10:137-139
11. Sobin LH, Wittekind CH (1997) TNM classification of malignant tumors, 5th edn. Wiley-Liss, New York
12. Jin M, Inoue S, Umemura T, Moriya J, Arakawa M, Nagashima K, Kato H (2001) Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II. Lung Cancer 34:207-218
13. Keum JS, Kong G, Yang SC, Shin DH, Park SS, Lee JH, Lee JD (1999) Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer. Br J Cancer 81:127-132
14. Keyomarsi K, Pardee AB (1993) Redundant cyclin overexpression and gene amplification in breast cancer cells. Proc Natl Acad Sci USA 90:1112-1116
15. Kwa HB, Michalides RJ, Dijkman JH, Mooi WJ (1996) The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer. Lung Cancer 14:207-217
16. Lukas J, Muller H, Bartkova J, Spitkovsky D, Kjerulff AA, Jansen-Durr P, Strauss M, Bartek J (1994) DNA tumor virus oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J Cell Biol 125:625-638
17. Marchetti A, Doglioni C, Barbareschi M, Buttitta F, Pellegrini S, Gaeta P, La Rocca R, Merlo G, Chella A, Angeletti CA, Dalla Palma P, Bevilacqua G (1998) Cyclin D1 and retinoblastoma susceptibility gene alterations in non-small cell lung cancer. Int J Cancer 75:187-192
18. Mate JL, Ariza A, Aracil C, Lopez D, Isamat M, Perez-Piteira J, Navas-Palacios JJ (1996) Cyclin D1 overexpression in non-small cell lung carcinoma: correlation with Ki67 labelling index and poor cytoplasmic differentiation. J Pathol 180:395-9
19. Matsushime H, Roussel MF, Ashmun RA, Sherr CJ (1991) Colony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle. Cell 65:701-713
20. Mishina T, Dosaka-Akita H, Kinoshita I, Hommura F, Morikawa T, Katoh H, Kawakami Y (1999) Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome. Br J Cancer 80:1289-1295
21. Muller H, Lukas J, Schneider A, Warthoe P, Bartek J, Eilers M, Strauss M (1994) Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 91:2945-2949
22. Naitoh H, Shibata J, Kawaguchi A, Kodama M, Hattori T (1995) Overexpression and localization of cyclin D1 mRNA and antigen in esophageal cancer. Am J Pathol 146:1161-1169
23. Nguyen VN, Mirejovsky P, Mirejovsky T, Melinova L, Mandys V (2000) Expression of cyclin D1, Ki-67 and PCNA in non-small cell lung cancer: prognostic significance and comparison with p53 and bcl-2. Acta Histochem 102:323-338
24. Nishida N, Fukuda Y, Komeda T, Kita R, Sando T, Furukawa M, Amenomori M, Shibagaki I, Nakao K, Ikenaga M (1994) Amplification and overexpression of the cyclin D1 gene in aggressive human hepatocellular carcinoma. Cancer Res 54:3107-3110
25. Nishio M, Koshikawa T, Yatabe Y, Kuroishi T, Suyama M, Nagatake M, Sugiura T, Ariyoshi Y, Mitsudomi T, Takahashi T (1997) Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers. Clin Cancer Res 3:1051-1058
26. Saitoh G, Sugio K, Ishida T, Sugimachi K (2001) Prognostic significance of p21waf1, cyclin D1 and retinoblastoma expression detected by immunohistochemistry in non-small cell lung cancer. Oncol Rep 8:737-743
27. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366:704-707
28. Spitkovsky D, Steiner P, Gopalkrishnan RV, Eilers M, Jansen-Durr P (1995) The role of p53 in coordinated regulation of cyclin D1 and p21 gene expression by the adenovirus E1A and E1B oncogenes. Oncogene 10:2421-2425
29. Volm M, Koomagi R (2000) Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival. Br J Cancer 82:1747-1754
30. World Health Organization (1981) Histological typing of lung tumors. International classification of tumors, 2nd edn. World Health Organization, Geneva
31. Zukerberg LR, Yang WI, Arnold A, Harris NL (1995) Cyclin D1 expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. Am J Clin Pathol 103:756-60